首页> Pulmonary therapy> Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.

Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： David,Slade

第一单位： US Medical Affairs, GSK, Research Triangle Park, NC, USA.

作者： David,Slade ^[1] ; Riju,Ray ^[1] ; Chad,Moretz ^[2] ; Guillaume,Germain ^[3] ; François,Laliberté ^[3] ; Qin,Shen ^[4] ; Mei Sheng,Duh ^[5] ; Sean D,MacKnight ^[3] ; Beth,Hahn ^[6]

作者单位： US Medical Affairs, GSK, Research Triangle Park, NC, USA. ^[1] US Value Evidence and Outcomes, GSK, Research Triangle Park, NC, USA. ^[2] Groupe D'Analyse, Ltée, Montréal, QC, Canada. ^[3] GSK, Collegeville, PA, USA. ^[4] Analysis Group, Inc., Boston, MA, USA. ^[5] US Value Evidence and Outcomes, GSK, Research Triangle Park, NC, USA. Beth.a.hahn@gsk.com. ^[6]

关键词 COPD Hospitalization Initial maintenance therapy Inpatient admission LAMA LAMA/LABA Readmission Tiotropium UMEC/VI Umeclidinium/vilanterol

DOI 10.1007/s41030-021-00151-y

PMID 33728597

发布时间 2024-08-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Pulmonary therapy

2021年7卷1期

203-219页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

点击下载本期目录封面

Pulmonary therapy

2021年7卷1期

203-219页

检索历史清除

Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.

Pulmonary therapy

相似文献

同项目论文

Pulmonary therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.

Pulmonary therapy

相似文献

同项目论文

Pulmonary therapy

相关期刊

检索历史清除